Acorai

Acorai is a Swedish medical device company developing a non-invasive cardiac and pulmonary pressure sensing device to improve heart failure management. The company's handheld device uses a patented SAVE Sensor System combining multiple sensors with machine learning to non-invasively estimate intracardiac pressures — data that previously required invasive catheterization procedures. By enabling continuous, outpatient monitoring of hemodynamic congestion, Acorai aims to help healthcare professionals personalize heart failure therapy, reduce hospitalizations, and improve patient outcomes. Founded in 2019 and headquartered in Helsingborg, Sweden, Acorai received FDA Breakthrough Device Designation in 2023, which recognizes devices that provide more effective treatment or diagnosis of life-threatening conditions.